CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...
Markets News, March 7, 2025: Stocks Close Higher After Fed's Powell Says Economy in Good Shape; S&P 500, Nasdaq Post 3rd Straight Weekly Decline ...